Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BVAC-C in HPV 16/18 Positive Cervical Cancer
NCT02866006Phase 2Completed
- Sponsor
- Cellid Co., Ltd.
- Start
- Oct 2016
- Primary completion
- Dec 2021
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of BVAC-C in Cervical Cancer (CC), sponsored by Cellid Co., Ltd.. Started Oct 2016; status: completed.
02
Drugs
BVAC-C
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02866006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866006.